Attached files

file filename
8-K/A - 8-K/A - MOCON INCa12-14819_18ka.htm
EX-99.2 - EX-99.2 - MOCON INCa12-14819_1ex99d2.htm
EX-23.1 - EX-23.1 - MOCON INCa12-14819_1ex23d1.htm
EX-99.1 - EX-99.1 - MOCON INCa12-14819_1ex99d1.htm

EXHIBIT 99.3

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

On April 2, 2012, MOCON, Inc. (MOCON) acquired all of the outstanding common shares of PBI-Dansensor A/S (Dansensor) for a total purchase price of DKK 112,000,000, which totals approximately $20.1 million inclusive of cash acquired of $0.8 million.  Approximately $13.6 million was paid in cash at closing and the remainder will be paid over four years pursuant to a secured note issued to PBI-Holding A/S by MOCON.  On March 28, 2012, in connection with the closing of the acquisition of Dansensor, MOCON entered into a Credit Agreement (the Agreement) with Wells Fargo Bank NA.  The Agreement provides for a four year, $5.0 million secured revolving line of credit, and a $3.5 million secured term loan that amortizes over four years.  At March 31, 2012, MOCON drew $7.5 million against the loans for purposes of the acquisition.

 

Dansensor is a manufacturer of specialized instrumentation for Modified Atmosphere Packaging (MAP) of foods, beverages, pharmaceuticals and other perishable items.  Dansensor designs quality control and assurance solutions for the food industry and other businesses that package their products in protective gas atmospheres.  Dansensor is headquartered in Denmark but operates worldwide, and has wholly owned subsidiaries in France, Italy, Spain, Germany and the United States.

 

The unaudited pro forma condensed combined balance sheet as of March 31, 2012 is based on historical consolidated balance sheets of MOCON and Dansensor and was prepared as if the acquisition had occurred on that date.  The unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2012 and the fiscal year ended December 31, 2011 have been prepared assuming the acquisition occurred at the beginning of the year ended December 31, 2011 and are based on historical consolidated statements of operations of MOCON and Dansensor.

 

The unaudited pro forma condensed combined financial statements are prepared for informational purposes only and are not indicative of the consolidated results of operations or financial position that MOCON would have reported had the acquisition occurred at the previous dates presented, nor do they project results of future operations as a consolidated entity.  The unaudited pro forma condensed combined financial statements do not reflect any operating efficiencies and/or cost savings that MOCON may achieve with respect to the combined business operations.

 

Pursuant to Article 11 of Regulation S-X, the historical financial information has been adjusted in the unaudited pro forma condensed combined financial statements to reflect pro forma events that are (i) directly attributable to the acquisitions, (ii) factually supportable, and (iii) with respect to the statements of operations, expected to have a continuing impact on the combined results of the businesses.

 



 

MOCON, INC.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2011

 

 

 

MOCON

 

Dansensor

 

Pro Forma

 

Pro Forma

 

 

 

Historical

 

Historical (1)

 

Adjustments

 

Combined

 

Sales:

 

 

 

 

 

 

 

 

 

Products

 

$

34,383,432

 

$

20,269,866

 

$

 

$

54,653,298

 

Consulting services

 

2,977,435

 

 

 

 

2,977,435

 

Total sales

 

37,360,867

 

20,269,866

 

 

57,630,733

 

 

 

 

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

 

 

 

 

Products

 

12,284,206

 

6,839,606

 

872,593

(I)

19,996,405

 

Consulting services

 

1,608,364

 

 

 

1,608,364

 

Total cost of sales

 

13,892,570

 

6,839,606

 

872,593

 

21,604,769

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

23,468,297

 

13,430,260

 

(872,593

)

36,025,964

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

12,941,350

 

9,839,164

 

240,760

(I)

23,021,274

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

2,402,566

 

1,427,916

 

594,155

(G)

4,424,637

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

8,124,381

 

2,163,180

 

(1,707,508

)

8,580,053

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

79,599

 

(42,053

)

(424,947

)(J)

(387,401

)

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

8,203,980

 

2,121,127

 

(2,132,455

)

8,192,652

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

2,753,062

 

535,282

 

(538,140

)(H)

2,750,204

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

5,450,918

 

$

1,585,845

 

$

(1,594,315

)

$

5,442,448

 

 

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

1.02

 

 

 

 

 

$

1.02

 

Diluted

 

0.98

 

 

 

 

 

0.98

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

5,342,900

 

 

 

 

 

5,342,900

 

Diluted

 

5,572,646

 

 

 

 

 

5,572,646

 

 


(1)        Converted from DKK to U.S. dollars at the average exchange rate for the year of 0.1869

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 



 

MOCON, INC.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

QUARTER ENDED MARCH 31, 2012

 

 

 

MOCON

 

Dansensor

 

Pro Forma

 

Pro Forma

 

 

 

Historical

 

Historical (1)

 

Adjustments

 

Combined

 

Sales:

 

 

 

 

 

 

 

 

 

Products

 

$

8,516,337

 

$

4,873,637

 

$

 

$

13,389,974

 

Consulting services

 

666,994

 

 

 

666,994

 

Total sales

 

9,183,331

 

4,873,637

 

 

14,056,968

 

 

 

 

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

 

 

 

 

Products

 

2,994,877

 

2,558,818

 

218,148

(I)

5,771,843

 

Consulting services

 

379,370

 

 

 

379,370

 

Total cost of sales

 

3,374,247

 

2,558,818

 

218,148

 

6,151,213

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

5,809,084

 

2,314,819

 

(218,148

)

7,905,755

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

3,777,673

 

1,513,888

 

60,190

(I)

5,351,751

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

733,539

 

457,499

 

(156,026

)(G)

1,035,012

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

1,297,872

 

343,432

 

(122,312

)

1,518,992

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

17,508

 

5,994

 

(106,237

)(J)

(82,735

)

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

1,315,380

 

349,426

 

(228,549

)

1,436,257

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

494,707

 

104,899

 

(68,611

)(H)

530,995

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

820,673

 

$

244,527

 

$

(159,938

)

$

905,262

 

 

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.15

 

 

 

 

 

$

0.17

 

Diluted

 

0.14

 

 

 

 

 

0.16

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

5,450,173

 

 

 

 

 

5,450,173

 

Diluted

 

5,691,783

 

 

 

 

 

5,691,783

 

 


(1)        Converted from DKK to U.S. dollars at the average exchange rate for the quarter of 0.1763

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 



 

MOCON, INC.

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

MARCH 31, 2012

 

 

 

MOCON

 

Dansensor

 

Pro Forma

 

Pro Forma

 

 

 

Historical

 

Historical (1)

 

Adjustments

 

Combined

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

15,982,890

 

$

832,669

 

$

(13,612,046

)(A)

$

3,203,513

 

Marketable securities, current

 

5,714,241

 

 

 

5,714,241

 

Trade accounts receivable, net

 

4,862,082

 

3,348,069

 

 

8,210,151

 

Other receivables

 

104,900

 

444,126

 

 

549,026

 

Inventories

 

4,608,666

 

2,045,992

 

897,863

(B)

7,552,521

 

Prepaid expenses

 

862,420

 

 

 

862,420

 

Deferred income taxes

 

821,028

 

 

 

821,028

 

Total current assets

 

32,956,227

 

6,670,856

 

(12,714,183

)

26,912,900

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, noncurrent

 

3,281,284

 

 

 

3,281,284

 

Property, plant and equipment, net

 

3,691,983

 

1,348,157

 

 

5,040,140

 

Goodwill

 

3,172,493

 

 

5,408,335

(C)

8,580,828

 

Investment in affiliated company

 

3,334,500

 

 

 

3,334,500

 

Technology rights and other intangibles, net

 

998,274

 

1,915,462

 

10,580,996

(C), (F)

13,494,732

 

Deferred income taxes

 

16,718

 

 

 

16,718

 

Other assets

 

87,543

 

117,442

 

 

204,985

 

TOTAL ASSETS

 

$

47,539,022

 

$

10,051,917

 

$

3,275,148

 

$

60,866,087

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

Current maturities of long-term debt

 

$

875,004

 

$

 

1,617,388

(A)

$

2,492,392

 

Revolving line of credit

 

4,000,000

 

 

 

4,000,000

 

Accounts payable

 

2,254,929

 

744,634

 

 

2,999,563

 

Compensation and other accrued expenses

 

2,179,373

 

2,766,584

 

 

4,945,957

 

Dividends payable

 

574,654

 

 

 

574,654

 

Deferred income taxes

 

 

 

224,466

(D)

224,466

 

Deferred revenue

 

492,653

 

 

 

492,653

 

Total current liabilities

 

10,376,613

 

3,511,218

 

1,841,854

 

15,729,685

 

 

 

 

 

 

 

 

 

 

 

Term note payable

 

2,624,996

 

 

 

2,624,996

 

Seller financed note payable

 

 

 

4,852,165

(A)

4,852,165

 

Deferred income taxes and other provisions

 

48,155

 

476,579

 

2,645,249

(D), (F)

3,169,983

 

Accrued income taxes

 

294,790

 

 

 

294,790

 

Total liabilities

 

13,344,554

 

3,987,797

 

9,339,268

 

26,671,619

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

 

 

 

Capital stock - undesignated

 

 

 

 

 

Common stock - $0.10 par value

 

547,290

 

3,586,000

 

(3,586,000

)(E)

547,290

 

Additional paid-in capital

 

3,193,810

 

 

 

3,193,810

 

Retained earnings

 

30,769,150

 

2,478,120

 

(2,478,120

)(E), (F)

30,769,150

 

Accumulated other comprehensive loss

 

(315,782

)

 

 

(315,782

)

Total stockholders’ equity

 

34,194,468

 

6,064,120

 

(6,064,120

)

34,194,468

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

47,539,022

 

$

10,051,917

 

$

3,275,148

 

$

60,866,087

 

 


(1)        Converted from DKK to U.S. dollars at the ending exchange rate for the quarter of 0.1793

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 



 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

Preliminary Estimated Purchase Price Allocation

 

The total preliminary estimated purchase price was allocated to the net assets acquired based upon their preliminary estimated fair values as of the close of business on April 2, 2012 as set forth below.  The excess of the preliminary purchase price over the preliminary net assets was recorded as goodwill.  The preliminary allocation of the purchase price was based upon a preliminary valuation and the estimates and assumptions are subject to change.  The preliminary estimated purchase price allocation for the acquisition is as follows (based upon a 0.1793 exchange rate as of April 2, 2012):

 

Cash and cash equivalents

 

$

832,669

 

Trade accounts receivable, net

 

3,348,069

 

Other receivables

 

444,126

 

Inventories

 

2,943,855

 

Property, plant and equipment

 

1,348,157

 

Other assets

 

117,442

 

Intangible assets

 

12,496,458

 

Total identifiable assets acquired

 

21,530,776

 

 

 

 

 

Accounts payable

 

744,633

 

Other accrued expenses

 

2,766,584

 

Deferred income tax-current

 

224,466

 

Deferred income tax-long-term

 

3,121,828

 

Total liabilities assumed

 

6,857,511

 

 

 

 

 

Net identifiable assets acquired

 

14,673,265

 

Goodwill

 

5,408,335

 

Total purchase price

 

$

20,081,600

 

 

The Company incurred transaction costs of approximately $400,000 relating to the acquisition which are included in the Company’s first quarter 2012 statement of operations.  These costs have not been backed-out on a pro forma basis.

 

1.  Pro Forma Adjustments:

 

The following pro forma and U.S. GAAP conversion adjustments are included in the unaudited pro forma condensed combined balance sheets:

 

(A)  To record cash paid by the Company as partial purchase consideration to the selling shareholders of Dansensor.  The total purchase price of DKK 112 million (approximately $20,000,000) was paid partially by a cash payment of $13,612,046 at closing, partially financed by a Credit Agreement with Wells Fargo Bank,with the remainder to be paid over four years via a seller financed note of approximately $6,470,000 which commenced on April 2, 2012, the date of closing.

 



 

(B)   To reflect the preliminary fair value adjustments for acquired work-in-process and finished goods inventory.

 

(C)   To reflect the preliminary estimated fair values of the intangible assets and goodwill acquired as follows:

 

Intangible asset

 

Assessed Fair Value

 

Trademark/Trade name

 

$

3,819,090

 

Developed technology

 

7,853,340

 

Customer relationships and other

 

824,028

 

 

 

$

12,496,458

 

 

The valuation of the acquired intangible assets is preliminary and may change in the final purchase price allocation.

 

(D)  To record the adjustment for deferred tax liabilities arising from the acquisition.  The deferred tax liability adjustment relates to the fair value adjustment of inventory and the addition of identifiable intangible assets that will be amortized for financial reporting purposes but will not be deductible for tax purposes.

 

(E)   To record the elimination of the historical stockholders’ equity of Dansensor.

 

(F)   To transition the Dansensor research and development expenses accounting treatment from Danish GAAP to U.S. GAAP. The cumulative effect on the balance sheet at March 31, 2012: $1,915,462 reduction of technology rights and other intangibles, net, reduction of deferred tax liabilities ($478,866) and reduction of retained earnings ($1,436,596).

 

The following pro forma and U.S. GAAP conversion adjustments are included in the unaudited pro forma condensed combined statements of operations:

 

(G)   To transition the Dansensor research and development expenses accounting treatment from Danish GAAP to U.S. GAAP.  Effects of this adjustment on net income are as follows:

 

a.     Fiscal 2011: ($594,155)

b.     Three months ended March 31, 2012: $156,026

 

In fiscal 2011, the development costs that were capitalized for Danish GAAP purposes exceeded the amount of amortization expense recorded for the year. Therefore, the net amount of $594,155 was recorded in these pro forma financial statements as additional expense to properly reflect U.S. GAAP reporting. For the three months ended March 31, 2012, the amount of amortization expense exceeded the amount of development costs that were capitalized. Therefore, the net amount of $156,026 was shown as a reduction of R&D expense to conform to U.S. GAAP.

 

(H)  To record the estimated tax impact of the adjustments for research and development expenses, amortization of intangibles, and interest expense at the effective rates for the historical periods presented.

 

(I)    To record adjustments to amortization expense related to intangible assets arising from the acquisition.  For purposes of the pro forma adjustments presented, we have used the following estimated asset lives:

 

Intangible asset

 

Asset Life

 

Trademark/Trade name

 

20 years

 

Developed technology

 

9 years

 

Customer relationships

 

9 years

 

 

 

 

 

 

The estimated asset lives are preliminary and may change in the final purchase price allocation.  Further, pro forma amortization expense has been calculated using the straight line method.

 



 

Upon completion of the valuation process, the Company may conclude that the intangible assets should be amortized on a basis other than straight line.

 

(J)    To record interest expense on the $4,000,000 secured revolving line of credit, the $3,500,000 secured term loan, and the $6,469,553 secured note issued to the seller.